½ÃÀ庸°í¼­
»óǰÄÚµå
1600516

ºñ¸¸ ¼ö¼ú¿ë µð¹ÙÀ̽º ½ÃÀå : µð¹ÙÀ̽º, ½Ã¼ú, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Bariatric Surgery Devices Market by Device (Gastric Balloon, Gastric Band, Surgical Stapler), Procedure (Adjustable Gastric Banding, Biliopancreatic Diversion with Duodenal Switch, Gastric Bypass), End User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 184 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ºñ¸¸ ¼ö¼ú¿ë µð¹ÙÀ̽º ½ÃÀåÀº 2023³â¿¡ 19¾ï 8,000¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, 2024³â¿¡´Â 21¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 7.61%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 33¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ºñ¸¸ ¼ö¼ú¿ë ±â±â´Â À§ ¿ìȸ¼ú, ½½¸®ºêÇü À§ ÀýÁ¦¼ú µî ¼ÒÈ­±â °èÅë¿¡ º¯È­¸¦ Áִ üÁß °¨·® ¼ö¼úÀ» µ½±â À§ÇØ °í¾ÈµÈ Ư¼ö ÀÇ·á±â±âÀÔ´Ï´Ù. ´ç´¢º´, °íÇ÷¾Ð, ½ÉÇ÷°ü Áúȯ°ú °°Àº ½É°¢ÇÑ °Ç°­»óÀÇ ¹®Á¦¸¦ ¾ß±âÇÏ´Â ºñ¸¸ Áõ°¡·Î ÀÎÇØ ÀÌ·¯ÇÑ ±â±â°¡ ÇÊ¿äÇÏ°Ô µÇ¾ú½À´Ï´Ù. ºñ¸¸ ¼ö¼ú ±â±âÀÇ ¿ëµµ¿¡´Â À½½Ä¹° ¼·Ã븦 ÁÙÀÌ´Â Á¦ÇÑÀû ½Ã¼ú°ú Ä®·Î¸® Èí¼ö¸¦ ÁÙÀÌ´Â Èí¼ö Àå¾Ö ½Ã¼úÀÌ Æ÷ÇԵ˴ϴÙ. ÃÖÁ¾»ç¿ëÀÚ´Â ÁÖ·Î º´¿ø, Ŭ¸®´Ð ¹× Àü¹® ºñ¸¸ Ä¡·á ¼¾ÅÍ·Î, ȯÀÚÀÇ °Ç°­À» È¿°úÀûÀ¸·Î °ü¸®Çϱâ À§ÇØ ½Å·ÚÇÒ ¼ö ÀÖ°í È¿À²ÀûÀÎ Àåºñ°¡ ÇÊ¿äÇÕ´Ï´Ù. ÀÌ ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î´Â ºñ¸¸À² Áõ°¡, ¼ö¼ú ÀåºñÀÇ ±â¼ú ¹ßÀü, ºñ¸¸°ú °ü·ÃµÈ °Ç°­ À§Çè¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡ µîÀÌ ÀÖ½À´Ï´Ù. ºñ¸¸À²ÀÌ ±ÞÁõÇϰí ÀÖ´Â ¾Æ½Ã¾ÆÅÂÆò¾ç°ú ¶óƾ¾Æ¸Þ¸®Ä« µî ½ÅÈï ½ÃÀå¿¡¼­ ±âȸ°¡ ÀÖ½À´Ï´Ù. À̵é Áö¿ªÀº Àα¸°¡ ¸¹°í ÀÇ·á ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, Å« ÀáÀç·ÂÀ» °¡Áö°í ÀÖ½À´Ï´Ù. ±×·¯³ª ºñ¸¸ ¼ö¼ú ¹× Àåºñ¿¡ ´ëÇÑ ³ôÀº ºñ¿ë, ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°Ç, ¼ö¼ú ÈÄ ÇÕº´Áõ ¹ß»ý °¡´É¼º µî ÇѰè¿Í °úÁ¦µµ Á¸ÀçÇÕ´Ï´Ù. ±×·³¿¡µµ ºÒ±¸ÇÏ°í ½ÃÀåÀº ±â¼ú Çõ½ÅÀÇ ±âȸ°¡ ¹«¸£ÀͰí ÀÖÀ¸¸ç, ƯÈ÷ Àúħ½ÀÀû ±â¼ú°ú º¸´Ù È¿°úÀûÀÎ ¼ö¼ú ÈÄ °ü¸® ¼Ö·ç¼ÇÀÇ °³¹ßÀÌ ÁøÇàµÇ°í ÀÖ½À´Ï´Ù. ·Îº¿ ¼ö¼úÀÇ ¹ßÀü°ú ¿µ»ó ±â¼úÀÇ °­È­´Â ¿¬±¸°³¹ßÀÇ ÀáÀç·ÂÀ» Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ ºñ¿ë È¿À²ÀûÀÎ ÀåºñÀÇ °³¹ßÀº ´õ ¸¹Àº ȯÀÚÃþÀÌ ¼ö¼ú¿¡ Á¢±ÙÇÒ ¼ö ÀÖ´Â ±âȸ¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù. ºñ¸¸ Ä¡·áÀÇ Çõ½ÅÀû ¼Ö·ç¼Ç¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ¼ö¿ä¿¡ ÈûÀÔ¾î ½ÃÀåÀº °æÀïÀûÀ̸鼭µµ ¼ºÀåÇÒ ¼ö Àִ ż¼¸¦ °®Ãß°í ÀÖ½À´Ï´Ù. ±â¾÷Àº Àü·«Àû Á¦ÈÞ ¹× ÆÄÆ®³Ê½Ê¿¡ ÁßÁ¡À» µÎ¾î ½ÃÀå ¹üÀ§¸¦ È®ÀåÇϰí źźÇÑ R&D Ȱµ¿À» ÅëÇØ ½ÃÀå¿¡¼­ ¿ìÀ§¸¦ Á¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü¹ÝÀûÀ¸·Î ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀåÀº º¹À⼺À» ±Øº¹Çϰí Áö¼Ó°¡´ÉÇÑ ¼ºÀåÀ» À§ÇØ ±â¼ú ¹ßÀüÀ» Ȱ¿ëÇÒ ÀÇÁö°¡ ÀÖ´Â ±â¾÷¿¡°Ô Å« ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ[2023] 19¾ï 8,000¸¸ ´Þ·¯
¿¹Ãø³â[2024] 21¾ï 3,000¸¸ ´Þ·¯
¿¹Ãø³â[2030] 33¾ï 2,000¸¸ ´Þ·¯
CAGR(%) 7.61%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ëÀ¸·Î ÀÎÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤, Àü·«Àû ÀÇ»ç°áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¿ªÀû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ¿ÏÈ­Çϰí, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • Àúħ½ÀÀû ±â¼úÀÇ °¡¿ë¼º ¹× ¼±È£µµ Áõ°¡
    • Àα¸ÀÇ ºñ¸¸°ú °úüÁß Áõ°¡
    • ½ÅÈï ±¹°¡°¡ÀÇ ºñ¸¸ ¼ö¼ú¿¡ ´ëÇÑ À¯¸®ÇÑ Á¤ºÎ ÁöÃâ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • °³¹ßµµ»ó±¹ÀÇ ¼÷·ÃµÈ Àü¹®°¡ ºÎÁ·
  • ½ÃÀå ±âȸ
    • ºñ¸¸ ¼ö¼ú¿ë ±â±âÀÇ »õ·Î¿î ±â¼ú ¹ßÀü
    • º¸Çè±Ý Áö±Þ ¹üÀ§¿Í ½ºÆù¼­¿¡ ÀÇÇÑ ºñ¸¸ ¼ö¼ú Áõ°¡
  • ½ÃÀå °úÁ¦
    • ¾ö°ÝÇÑ ±ÔÁ¦ Áöħ ¹× ³ôÀº Àåºñ ºñ¿ë

Portre's Five Forces: ºñ¸¸ ¼ö¼ú¿ë ±â±â ½ÃÀå °ø·«À» À§ÇÑ Àü·« Åø

Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ ÅøÀÔ´Ï´Ù. Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®À» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ºñ¸¸ ¼ö¼ú¿ë ±â±â ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ºñ¸¸ ¼ö¼ú¿ë ±â±â ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¸ÅÃâ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­ ¹× ÅëÇÕ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®À» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º ºñ¸¸ ¼ö¼ú¿ë ±â±â ½ÃÀå¿¡¼­°ø±Þ¾÷ü ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ ÅøÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀº º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ±¸ºÐÇÏ¿© »ç¿ëÀÚ°¡ Àü·«Àû¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù. ½Äº°ÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â Á¾ÇÕÀûÀÎ ½ÃÀå ºÐ¼®À» Á¦°øÇÕ´Ï´Ù. :

1. ½ÃÀå ħÅõµµ : ¾÷°è ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅ͸¦ Æ÷ÇÔÇÑ ÇöÀç ½ÃÀå ȯ°æ¿¡ ´ëÇÑ »ó¼¼ÇÑ °ËÅä.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸°³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù. :

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÔ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå °³¿ä

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ºñ¸¸ ¼ö¼ú¿ë µð¹ÙÀ̽º ½ÃÀå : µð¹ÙÀ̽ºº°

  • À§³» dz¼±
  • À§¹êµå
  • ¿Ü°ú¿ë ½ºÅ×ÀÌÇ÷¯
  • ºÀÇÕ»ç

Á¦7Àå ºñ¸¸ ¼ö¼ú¿ë µð¹ÙÀ̽º ½ÃÀå : ½Ã¼úº°

  • Á¶Àý¼ºÀ§¹êµù
  • ½ÊÀÌÁöÀå ½ºÀ§Ä¡¿¡ ÀÇÇÑ ´ãÃé ¹ÙÀÌÆÐ½º¼ú
  • À§ ¹ÙÀÌÆÐ½º
  • ¹Ì´Ï À§ ¹ÙÀÌÆÐ½º
  • ºñħ½À¼º ºñ¸¸ ¼ö¼ú
  • ºñ¸¸ ¼ö¼ú Àç¼ö¼ú
  • ½½¸®ºê À§ÀýÁ¦¼ú

Á¦8Àå ºñ¸¸ ¼ö¼ú¿ë µð¹ÙÀ̽º ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • Ŭ¸®´Ð
  • º´¿ø

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ ºñ¸¸ ¼ö¼ú¿ë µð¹ÙÀ̽º ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ºñ¸¸ ¼ö¼ú¿ë µð¹ÙÀ̽º ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ºñ¸¸ ¼ö¼ú¿ë µð¹ÙÀ̽º ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®

±â¾÷ ¸®½ºÆ®

  • BIOTRONIK SE & Co KG
  • Integra LifeSciences Corporation
  • GI Dynamics Inc.
  • Abbott Laboratories
  • Stryker Corporation
  • Apollo Endosurgery, Inc.
  • Grena Ltd.
  • Geyi Medical Instrument
  • Zimmer Biomet Holdings, Inc.
  • Medtronic PLC
  • Intuitive Surgical Inc.
  • B. Braun SE
  • Olympus Corporation
  • ReShape Lifesciences, Inc.
  • Spatz FGIA, Inc.
  • Asensus Surgical, Inc.
  • Standard Bariatrics, Inc.
  • Johnson & Johnson Private Limited
  • Edwards Lifesciences
  • AMI GmbH
  • USGI Medical Inc.
  • Mediflex Surgical Products
  • Boston Scientific Corporation
  • Allurion S.a.s.
  • Cousin Biotech
  • CONMED Corporation
KSA 24.12.05

The Bariatric Surgery Devices Market was valued at USD 1.98 billion in 2023, expected to reach USD 2.13 billion in 2024, and is projected to grow at a CAGR of 7.61%, to USD 3.32 billion by 2030.

Bariatric surgery devices are specialized medical tools designed to aid in weight-loss surgeries that alter the digestive system, such as gastric bypass and sleeve gastrectomy. These devices are necessary due to the rising prevalence of obesity, which has serious health implications like diabetes, hypertension, and cardiovascular diseases. Applications of bariatric surgery devices include restrictive procedures to reduce food intake and malabsorptive procedures to decrease calorie absorption. End-users are primarily hospitals, clinics, and specialized bariatric centers, which require reliable and efficient devices to manage patient health effectively. Key growth factors influencing this market include increasing obesity rates, technological advancements in surgical devices, and rising awareness about obesity-related health risks. Opportunities lie in emerging markets such as Asia-Pacific and Latin America, where obesity rates are climbing rapidly. These regions present immense potential due to their large populations and increasing healthcare infrastructure investments. However, limitations and challenges include high costs associated with bariatric surgeries and devices, stringent regulatory requirements, and the potential for postoperative complications. Despite these challenges, the market is ripe for innovation, especially in developing minimally invasive techniques and more effective postoperative care solutions. Advances in robotic surgery and enhanced imaging technologies offer potential areas for research and development. Additionally, creating cost-effective devices can make surgeries accessible to a broader patient base. The market is competitive yet poised for growth, driven by the continuous demand for innovative solutions to combat obesity. Companies should focus on strategic collaborations and partnerships to expand their reach and engage in robust R&D activities to stay ahead in the market. Overall, the bariatric surgery devices market presents significant opportunities for companies willing to navigate its complexities and leverage technological advancements for sustainable growth.

KEY MARKET STATISTICS
Base Year [2023] USD 1.98 billion
Estimated Year [2024] USD 2.13 billion
Forecast Year [2030] USD 3.32 billion
CAGR (%) 7.61%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bariatric Surgery Devices Market

The Bariatric Surgery Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising Availability and Preference for Minimally Invasive Techniques
    • Increasing Obesity and Overweight among Population
    • Favorable Government Expenditure for Bariatric Surgery from Developed Economies
  • Market Restraints
    • Lack of Trained Professionals in Developing Regions
  • Market Opportunities
    • Emerging Technological Advancements in Bariatric Surgery Devices
    • Increasing Reimbursement Coverage and Sponsored Bariatric Surgeries
  • Market Challenges
    • Strict Regulatory Guidelines and High Cost of the Devices

Porter's Five Forces: A Strategic Tool for Navigating the Bariatric Surgery Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bariatric Surgery Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bariatric Surgery Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bariatric Surgery Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bariatric Surgery Devices Market

A detailed market share analysis in the Bariatric Surgery Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bariatric Surgery Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bariatric Surgery Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Bariatric Surgery Devices Market, highlighting leading vendors and their innovative profiles. These include BIOTRONIK SE & Co KG, Integra LifeSciences Corporation, GI Dynamics Inc., Abbott Laboratories, Stryker Corporation, Apollo Endosurgery, Inc., Grena Ltd., Geyi Medical Instrument, Zimmer Biomet Holdings, Inc., Medtronic PLC, Intuitive Surgical Inc., B. Braun SE, Olympus Corporation, ReShape Lifesciences, Inc., Spatz FGIA, Inc., Asensus Surgical, Inc., Standard Bariatrics, Inc., Johnson & Johnson Private Limited, Edwards Lifesciences, AMI GmbH, USGI Medical Inc., Mediflex Surgical Products, Boston Scientific Corporation, Allurion S.a.s., Cousin Biotech, and CONMED Corporation.

Market Segmentation & Coverage

This research report categorizes the Bariatric Surgery Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Device, market is studied across Gastric Balloon, Gastric Band, Surgical Stapler, and Sutures.
  • Based on Procedure, market is studied across Adjustable Gastric Banding, Biliopancreatic Diversion with Duodenal Switch, Gastric Bypass, Mini-Gastric Bypass, Non-Invasive Bariatric Surgery, Revision Bariatric Surgery, and Sleeve Gastrectomy.
  • Based on End User, market is studied across Ambulatory Surgery Centers, Clinics, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising Availability and Preference for Minimally Invasive Techniques
      • 5.1.1.2. Increasing Obesity and Overweight among Population
      • 5.1.1.3. Favorable Government Expenditure for Bariatric Surgery from Developed Economies
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of Trained Professionals in Developing Regions
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging Technological Advancements in Bariatric Surgery Devices
      • 5.1.3.2. Increasing Reimbursement Coverage and Sponsored Bariatric Surgeries
    • 5.1.4. Challenges
      • 5.1.4.1. Strict Regulatory Guidelines and High Cost of the Devices
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Device: Growing preference towards gastric balloons in minimally invasive bariatric surgery
    • 5.2.2. Procedure: Rising trends towards non-invasive bariatric surgery
    • 5.2.3. End User: Rising demand for bariatric surgery devices from hospitals due to the complexity and range of procedures performed
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental
  • 5.5. Client Customization

6. Bariatric Surgery Devices Market, by Device

  • 6.1. Introduction
  • 6.2. Gastric Balloon
  • 6.3. Gastric Band
  • 6.4. Surgical Stapler
  • 6.5. Sutures

7. Bariatric Surgery Devices Market, by Procedure

  • 7.1. Introduction
  • 7.2. Adjustable Gastric Banding
  • 7.3. Biliopancreatic Diversion with Duodenal Switch
  • 7.4. Gastric Bypass
  • 7.5. Mini-Gastric Bypass
  • 7.6. Non-Invasive Bariatric Surgery
  • 7.7. Revision Bariatric Surgery
  • 7.8. Sleeve Gastrectomy

8. Bariatric Surgery Devices Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgery Centers
  • 8.3. Clinics
  • 8.4. Hospitals

9. Americas Bariatric Surgery Devices Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Bariatric Surgery Devices Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Bariatric Surgery Devices Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. ReShape Lifesciences Receives FDA PMA Supplement Approval for its Next-Generation Lap-Band 2.0 FLEX
    • 12.3.2. Medtronic will Distribute Allurion's Swallowable Weight-Loss Balloon
    • 12.3.3. AdventHealth Redmond Launches New Metabolic and Bariatric Surgery Program

Companies Mentioned

  • 1. BIOTRONIK SE & Co KG
  • 2. Integra LifeSciences Corporation
  • 3. GI Dynamics Inc.
  • 4. Abbott Laboratories
  • 5. Stryker Corporation
  • 6. Apollo Endosurgery, Inc.
  • 7. Grena Ltd.
  • 8. Geyi Medical Instrument
  • 9. Zimmer Biomet Holdings, Inc.
  • 10. Medtronic PLC
  • 11. Intuitive Surgical Inc.
  • 12. B. Braun SE
  • 13. Olympus Corporation
  • 14. ReShape Lifesciences, Inc.
  • 15. Spatz FGIA, Inc.
  • 16. Asensus Surgical, Inc.
  • 17. Standard Bariatrics, Inc.
  • 18. Johnson & Johnson Private Limited
  • 19. Edwards Lifesciences
  • 20. AMI GmbH
  • 21. USGI Medical Inc.
  • 22. Mediflex Surgical Products
  • 23. Boston Scientific Corporation
  • 24. Allurion S.a.s.
  • 25. Cousin Biotech
  • 26. CONMED Corporation
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦